natgillin/translations-raw huggingface dataset:
ob upoštevanju sporočila Komisije z dne 12. maja 2004 z naslovom "K evropski strategiji za nanotehnologijo" ( KOM(2004)0338 ),
having regard to the Commission Communication of 12 May 2004 entitled "Towards a European strategy for nanotechnology" ( COM(2004)0338 ),
ob upoštevanju sporočila Komisije z dne 7. junija 2005 z naslovom "Nanoznanosti in nanotehnologije: Akcijski načrt za Evropo 2005–2009" ( KOM(2005)0243 ) ("akcijski načrt") ter svoje resolucije z dne 28. septembra 2006 UL C 306 E, 15.12.2006, str.
having regard to the Commission Communication of 7 June 2005 entitled "Nanosciences and nanotechnologies: An action plan for Europe 2005-2009" ( COM(2005)0243 ) ("the action plan") and to its resolution of 28 September 2006 OJ C 306 E, 15.12.2006, p.
o tem akcijskem načrtu,
on the action plan,
ob upoštevanju sporočila Komisije z dne 6. septembra 2007 z naslovom "Nanoznanosti in nanotehnologije: Akcijski načrt za Evropo 2005–2009.
having regard to the Commission Communication of 6 September 2007 "Nanosciences and nanotechnologies: An action plan for Europe 2005-2009.
Prvo poročilo o izvajanju 2005–2007" ( KOM(2007)0505 ),
First Implementation Report 2005-2007" ( COM(2007)0505 ),
ob upoštevanju mnenja Znanstvenega odbora za potrošniške proizvode (SCCP) o varnosti nanomaterialov v kozmetiki Mnenje o varnosti nanomaterialov v kozmetičnih izdelkih; 18. december 2007; http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_123.pdf
having regard to the opinion of the Scientific Committee on Consumer Products (SCCP) on the safety of nanomaterials in cosmetics Opinion on Safety of nanomaterials in cosmetic products; 18 December 2007; http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_123.pdf
ob upoštevanju priporočila Komisije o kodeksu ravnanja za odgovorno raziskovanje na področju nanoznanosti in nanotehnologije ( KOM(2008)0424 ) ("kodeks ravnanja"),
having regard to the Commission Recommendation on a code of conduct for responsible nanosciences and nanotechnologies research ( COM(2008)0424 ) ("Code of Conduct"),
ob upoštevanju mnenja evropske skupine za etiko v znanosti in novih tehnologijah (EGE) pri Evropski komisiji o etičnih vidikih nanomedicine
having regard to the opinion from the European Group on Ethics in Science and New Technologies to the European Commission on the ethical aspects of nanomedicine
Mnenje št. 21, 17. januar 2007.
Opinion No 21, 17 January 2007.
ob upoštevanju Uredbe (ES) št. 1907/2006 Evropskega parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) UL L 396, 30.12.2006, str.
having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) OJ L 396, 30.12.2006, p.
ob upoštevanju Direktive 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet UL L 123, 24.4.1998, str.
having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market OJ L 123, 24.4.1998, p.
ob upoštevanju Direktive Sveta 89/391/EGS z dne 12. junija 1989 o uvajanju ukrepov za spodbujanje izboljšav varnosti in zdravja delavcev pri delu UL L 183, 29.6.1989, str.
having regard to Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work OJ L 183, 29.6.1989, p.
ter njenih hčerinskih direktiv,
and its daughter directives,
ter specifične zakonodaje o proizvodih, zlasti Direktive Sveta 76/768/EGS z dne 27. julija 1976 o približevanju zakonodaje držav članic v zvezi s kozmetičnimi izdelki UL L 262, 27.9.1976, str.
as well as specific product legislation, in particular Council Directive 76/768/EEC of 27 July 1976 on approximation of laws of the Member States relating to cosmetic products OJ L 262, 27.9.1976, p.
, Uredbe (ES) št. 1333/2008 Evropskega parlamenta in Sveta z dne 16. decembra 2008 o aditivih za živila UL L 354, 31.12.2008, str.
, Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives OJ L 354, 31.12.2008, p.
, Uredbe (ES) št. 1830/2003 Evropskega parlamenta in Sveta z dne 22. septembra 2003 o sledljivosti in označevanju gensko spremenjenih organizmov ter sledljivosti živil in krme, proizvedenih iz gensko spremenjenih organizmov UL L 268, 18.10.2003, str.
, Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms OJ L 268, 18.10.2003, p.
, ter Uredbe (ES) št. 258/97 Evropskega parlamenta in Sveta z dne 27. januarja 1997 v zvezi z novimi živili in novimi živilskimi sestavinami UL L 43, 14.2.1997, str.
, and Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients OJ L 43, 14.2.1997, p.
ob upoštevanju okoljevarstvene zakonodaje Skupnosti, zlasti Direktive 2008/1/ES Evropskega parlamenta in Sveta z dne 15. januarja 2008 o celovitem preprečevanju in nadzorovanju onesnaževanja UL L 24, 29.1.2008, str.
having regard to Community environmental legislation, in particular Directive 2008/1/EC of the European Parliament and of the Council of 15 January 2008 concerning integrated pollution prevention and control OJ L 24, 29.1.2008, p.
ter Direktive 2006/12/ES Evropskega parlamenta in Sveta z dne 5. aprila 2006 o odpadkih UL L 114, 27.4.2006, str.
and Directive 2006/12/EC of the European Parliament and of the Council of 5 April 2006 on waste OJ L 114, 27.4.2006, p.
ob upoštevanju poročila Odbora za okolje, javno zdravje in varnost hrane in mnenja Odbora za zaposlovanje in socialne zadeve ( A6-0255/2009 ),
having regard to the report of the Committee on the Environment, Public Health and Food Safety and the opinion of the Committee on Employment and Social Affairs ( A6-0255/2009 ),
ker uporaba nanomaterialov in nanotehnologij (v nadaljevanju: nanomateriali) obeta pomembne dosežke z mnogimi koristmi v številnih uporabah za potrošnike, paciente in okolje, saj imajo lahko nanomateriali drugačne ali nove lastnosti v primerjavi z isto snovjo ali materialom v običajni obliki,
whereas the use of nanomaterials and nanotechnologies (hereinafter referred to as "nanomaterials") promises important advances with multiple benefits in innumerable applications for consumers, patients and the environment, as nanomaterials can provide different or new properties compared to the same substance or material in normal form,
ker bodo dosežki v zvezi z nanomateriali pomembno vplivali na sprejemanje političnih odločitev na področju javnega zdravja, zaposlovanja, varnosti in zdravja pri delu, informacijske družbe, energetike, prometa, varnosti in vesolja,
whereas the advances in nanomaterials are expected to have significant influence on policy decisions in the fields of public health, employment, occupational safety and health, information society, energy, transport, security and space,
ker kljub oblikovani evropski strategiji za nanotehnologije in dodeljenim sredstvom za raziskave v nanoznanosti v višini približno 3 500 000 000 EUR za sedmi okvirni program Evropske skupnosti za raziskave, tehnološki razvoj in predstavitvene dejavnosti (2007 do 2013) Evropska unija zaostaja v primerjavi z njenimi največjimi tekmicami, ki so Združene države Amerike, Japonska in Južna Koreja, ki predstavljajo več kot polovico naložb in imajo dve tretjini prijavljenih patentov na svetovni ravni,
whereas despite the introduction of a specific European strategy on nanotechnologies and the subsequent allocation of approximately EUR 3 500 000 000 for research in nanosciences for the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007-2013) (FP7), the European Union is lagging behind its current main competitors – the USA, Japan and South Korea – who account for over half of the investment and two-thirds of the patents filed worldwide,
ker lahko nanomateriali po drugi strani zaradi svoje majhnosti pomenijo nova velika tveganja, kot so večja reaktivnost in prenosljivost, kar lahko privede do večje toksičnosti v kombinaciji z neomejenim dostopom do človeškega telesa in lahko vključuje povsem drugačne mehanizme motenj v fiziološkem delovanju ljudi in okolja,
whereas nanomaterials on the other hand potentially present significant new risks due to their minute size, such as increased reactivity and mobility, possibly leading to increased toxicity in combination with unrestricted access to the human body, and possibly involving quite different mechanisms of interference with the physiology of human and environmental species,
ker lahko varen razvoj nanomaterialov pomembno prispeva h konkurenčnosti gospodarstva Evropske unije in uresničevanju lizbonske strategije,
whereas the safe development of nanomaterials can make an important contribution to the competitiveness of the European Union's economy and to the achievement of the Lisbon strategy,
ker je za sedanjo razpravo o nanomaterialih značilno pomanjkanje informacij in znanja, kar povzroča nesoglasja, zapleta pa se že na ravni opredelitve:
whereas the current discussion about nanomaterials is characterised by a significant lack of knowledge and information, leading to disagreement starting at the level of definitions:
v zvezi z velikostjo: približna določitev velikosti ("približno 100 nm ali manj") ali točna opredelitev razpona velikosti ("med 1 in 100 nm"),
concerning the size: approximate indication of the size ("in the order of 100 nm or less") versus a specific size range ("between 1 and 100 nm"),
v zvezi z drugačnimi/novimi lastnostmi: drugačne/nove lastnosti zaradi razlike v velikosti, skupaj s številom delcev, površinsko strukturo in površinsko dejavnostjo, kot neodvisno merilo, ali uporaba takih lastnosti kot dodatnega merila za opredelitev nanomaterialov,
concerning different/new properties: different/new properties due to size effects, including particle number, surface structure and surface activity, as an independent criterion versus using such properties as an additional criterion for the definition of nanomaterials,
v zvezi s problematičnimi lastnostmi: ali naj se opredelitev nanomaterialov omeji na nekatere lastnosti (na primer netopne ali težko razgradljive nanomateriale) ali ne,
concerning problematic properties: limitation of the definition of nanomaterials to certain properties (e.g. insoluble or persistent), or not making such limitations,
ker zaenkrat ni v celoti oblikovanega nabora usklajenih opredelitev, čeprav je na voljo oziroma v pripravi nekaj mednarodnih standardov, v katerih je "nanovelikost" opredeljena kot "ena ali več dimenzij v velikosti 100 nm ali manj" in ki pogosto razlikujejo med:
whereas a fully developed set of harmonised definitions is not currently available although a number of international standards are either available or in progress, defining "nanoscale" as "having one or more dimensions of the order of 100 nm or less", and often distinguishing between:
"nanopredmeti", opredeljenimi kot "diskretni materiali z eno, dvema ali tremi dimenzijami v nanovelikosti", tj. kot materiali, sestavljeni iz posameznih predmetov zelo majhnih dimenzij;
nano-objects, defined as "discrete pieces of materials with one, two or three external dimensions at the nanoscale", i.e. as materials constituted by isolated objects with very small dimensions,
nanostrukturnimi materiali, opredeljenimi kot materiali, "ki imajo notranjo ali površinsko strukturo v nanovelikosti", npr. z vrzelmi majhnih dimenzij,
nano-structured materials, defined as materials "having an internal or surface structure at the nanoscale", e.g. exhibiting cavities of small dimensions,
ker ni na voljo jasnih informacij o dejanski rabi nanomaterialov v izdelkih za potrošnike, kot v naslednjih primerih:
whereas there is no clear information about the actual use of nanomaterials in consumer products, for instance:
seznami priznanih ustanov navajajo, da je na trgu več kot 800 izdelkov za potrošnike na osnovi nanomaterialov, ki jih kot take navajajo proizvajalci, vendar panožna združenja istih proizvajalcev dvomijo o resničnosti teh navedb, saj naj bi bile pretirane, hkrati pa sami ne navajajo nobenih podatkov,
while inventories by renowned institutions list more than 800 manufacturer-identified nanotechnology-based consumer products currently on the market, trade associations of the same manufacturers question these figures, on the basis that they are overestimations, without providing any concrete figures themselves,
podjetja zaradi pozitivnega tržnega učinka izraza "nanomateriali" brez zadržkov uporabljajo trditve o njihovi uporabi, po drugi strani pa so odločno proti objektivnim zahtevam po označevanju,
while companies happily use "nano-claims", as the term "nano" seems to have a positive marketing effect, they are strictly opposed to objective labelling requirements,
ker so za zagotavljanje zanesljivih informacij o uporabi nanomaterialov potrebne jasne zahteve za obveščanje o uporabi nanomaterialov, informacijah za potrošnike ter izvajanje Direktive 2006/114/ES v celoti,
whereas clear notification requirements on the use of nanomaterials, information to consumers as well as full enforcement of Directive 2006/114/EC are necessary to provide reliable information on the use of nanomaterials,
ker poteka velika razprava o možnosti ocenjevanja varnosti nanomaterialov, ker znanstveni odbori in agencije Evropske unije opozarjajo na velike pomanjkljivosti v ključnih podatkih in celo v metodah pridobivanja takšnih podatkov; ker mora zato Evropska unija bolj vlagati v ustrezno ocenjevanje nanomaterialov, da bi odpravila vrzeli v znanju ter da bi čim prej v sodelovanju s svojimi agencijami in mednarodnimi partnerji razvila metode za ocenjevanje ter ustrezno in usklajeno meroslovje in nomenklaturo,
whereas there is a major debate about the possibility of assessing the safety of nanomaterials; whereas the scientific committees and Agencies of the European Union point to major deficiencies not only in key data, but even in methods of obtaining such data; whereas the European Union thus needs to invest more into adequate assessment of nanomaterials to close the knowledge gaps and to develop and implement as fast as possible, and, in collaboration with its agencies and international partners, methods of evaluation and an appropriate and harmonised metrology and nomenclature,
ker je odbor SCENIHR ugotovil nekaj posebnih nevarnosti za zdravje in strupene učinke na okoljske organizme pri nekaterih nanomaterialih; ker je odbor SCENIHR ugotovil tudi splošno pomanjkanje visokokakovostnih podatkov o izpostavljenosti za ljudi in okolje in zaključil, da je treba nadaljevati z razvojem, preverjanjem in standardizacijo znanja o metodologiji za ocene izpostavljenosti in ugotavljanje nevarnosti,
whereas SCENIHR identified some specific health hazards as well as toxic effects on environmental organisms for some nanomaterials; whereas SCENIHR furthermore found a general lack of high-quality exposure data both for humans and the environment, concluding that the knowledge on the methodology for both exposure estimates and hazard identification needs to be further developed, validated and standardised,
ker so sedanja finančna sredstva za raziskave, namenjena okoljskim, zdravstvenim in varnostnim vidikom nanomaterialov v sedmem okvirnem programu za raziskave veliko premajhna, ker so tudi ocenjevalna merila za odobritev raziskovalnih projektov za ocenjevanje varnosti nanomaterialov v sedmem okvirnem programu preveč omejevalna (tj. da so ozko usmerjena k inovacijam) in tako ne spodbujajo v zadostni meri nujnega razvoja znanstvenih metod za ocenjevanje nanomaterialov, ker je bistveno, da se nameni dovolj sredstev za financiranje raziskav o varnem razvoju in uporabi nanomaterialov,
whereas current funding for research into the environmental, health and safety aspects of nanomaterials in FP7 is far too low; whereas moreover the evaluation criteria for granting research projects to assess the safety of nanomaterials under FP7 are too restrictive (i.e. they have a narrow innovation bias), and thus do not sufficiently promote the urgent development of scientific methods to assess nanomaterials; whereas it is essential to allocate sufficient resources for research on the safe development and use of nanomaterials,
ker znanje o morebitnih vplivih nanomaterialov na zdravje in okolje precej zaostaja za hitrostjo dogajanja na trgu glede na zelo hiter razvoj na področju nanomaterialov in s tem sproža temeljna vprašanja o tem, ali je s sedanjimi uredbami mogoče v realnem času obravnavati nove tehnologije, kot so nanomateriali,
whereas knowledge about potential health and environmental impacts of nanomaterials lags significantly behind the pace of market developments in light of the very rapid developments in the field of nanomaterials, thus raising fundamental questions about the ability of the current regulations to deal with emerging technologies such as nanomaterials in "real time",
ker je Parlament v skladu s previdnostnim načelom v svoji resoluciji z dne 28. septembra 2006 o nanoznanostih in nanotehnologijah pozval k raziskavi o učinkih nanodelcev, ki niso lahko topni ali biološko razgradljivi, preden se takšni delci začnejo proizvajati in dajati na trg,
whereas, in its resolution of 28 September 2006 on nanosciences and nanotechnologies Parliament had called for investigation of the effects of nanoparticles that are not readily soluble or biodegradable, in accordance with the precautionary principle, before such particles are put into production and placed on the market,
ker bi bilo treba nanomateriale vključiti v mnogoteren, diferenciran in prilagodljiv zakonodajni okvir, ki bi temeljil na previdnostnem načelu Sporočilo Komisije z dne 2. februarja 2000 o previdnostnem načelu ( KOM(2000)0001 ).
whereas nanomaterials should be covered by a multi-faceted, differentiated and adaptive body of law based on the precautionary principle Commission Communication of 2 February 2000 on the precautionary principle ( COM(2000)0001 ).
, na načelu odgovornosti proizvajalca ter na načelu, da plača povzročitelj obremenitve, da bi se zagotovila varna proizvodnja, uporaba in odlaganje nanomaterialov pred dajanjem tehnologije na trg, pri čemer se je treba izogniti avtomatskem poseganju po splošni prepovedi ali enakemu obravnavanju različnih načinov uporabe nanomaterialov,
, the principle of producer responsibility and the polluter-pays principle to ensure the safe production, use and disposal of nanomaterials before the technology is put on the market, while avoiding systematic recourse to general moratoria or undifferentiated treatment of different applications of nanomaterials,
ker skoraj neomejena uporaba nanotehnologij v različnih sektorjih, kot so elektronika, tekstil, biomedicina, izdelki za osebno nego, čistila, živilski ali energetski sektor, onemogoča vzpostavitev enotnega ureditvenega okvira na ravni Skupnosti,
whereas the almost infinite application of nanotechnologies to such diverse sectors as electronics, textiles, biomedicals, personal care products, cleaning products, food or energy makes it impossible to introduce a single regulatory framework at Community level,
ker je bilo v okviru uredbe REACH že dogovorjeno, da je potrebno nadaljnje usmerjanje in svetovanje o nanomaterialih, zlasti o prepoznavanju snovi, ter prilagajanje metod ocenjevanja tveganja, ker natančnejši ogled uredbe REACH razkrije več pomanjkljivosti v zvezi z nanomateriali,
whereas, in the context of REACH, it has already been agreed that further guidance and advice on nanomaterials, in particular on substance identification, as well as an adaptation of risk assessment methods is needed; whereas a closer look at REACH reveals several further deficiencies to deal with nanomaterials,
ker v odsotnosti določb, ki bi se nanašale na nanomateriale, obstaja tveganje za nepravilno uporabo zakonodaje o odpadkih,
whereas waste legislation in the absence of nano-specific provisions may not apply correctly,
ker nanomateriali skozi celotni življenjski cikel pomenijo velik izziv za zdravje in varnost pri delu, saj je tem materialom izpostavljenih veliko delavcev v proizvodni verigi, ne da bi vedeli, ali se izvajajo varnostni postopki in ali so varnostni ukrepi ustrezni in učinkoviti; ugotavlja, da se bo v prihodnje še povečevalo število in raznolikost skupin delavcev, izpostavljenih učinkom nanomaterialov,
whereas nanomaterials, throughout their whole life cycle, raise major challenges for occupational health and safety, as many workers along the production chain are exposed to those materials without knowing whether the safety procedures implemented and the protection measures taken are adequate and efficient; notes that the number and diversity of workers exposed to the effects of nanomaterials are expected to increase in the future,
ker je v številnih predlogih sprememb v zvezi z nanomateriali, ki so bili sprejeti v dogovoru iz prve obravnave med Svetom in Evropskim parlamentom v okviru prenovitve direktive o kozmetičnih izdelkih Stališče Evropskega parlamenta z dne 24. marca 2009, Sprejeta besedila, P6_TA(2009)0158 .
whereas the significant amendments concerning nanomaterials adopted in a first reading agreement between the Council and the European Parliament in the context of the recast of the cosmetics directive Position of the European Parliament of 24 March 2009, Texts adopted, P6_TA(2009)0158 .
, ter v številnih predlogih sprememb, ki jih je Evropski parlament sprejel na prvi obravnavi v okviru revizije uredbe o novih živilih Stališče Evropskega parlamenta z dne 25. marca 2009, Sprejeta besedila, P6_TA(2009)0171 .
, and the significant amendments adopted by the European Parliament in the first reading of the review of the regulation on novel food Position of the European Parliament of 25 March 2009, Texts adopted, P6_TA(2009)0171 .
, poudarjeno, da je treba za ustrezno obravnavo nanomaterialov spremeniti zakonodajo Skupnosti,
, respectively, highlight the need to amend relevant Community legislation to address nanomaterials adequately,
ker je sedanja razprava o regulativnih vidikih nanomaterialov močno omejena na strokovnjake, čeprav lahko zaradi nanomaterialov pride do obsežnih družbenih sprememb, za kar je potrebna široka javna razprava,
whereas the current debate about regulatory aspects of nanomaterials is largely limited to expert circles, even though nanomaterials have the potential to bring about far-ranging societal change, which requires wide-ranging public consultation,
ker bi lahko široka uporaba patentov za nanomateriale, visoki stroški za patentiranje in pomanjkanje olajšav za dostop do patentov za zelo mala ter za mala in srednja podjetja zavrla nadaljnje inovacije,
whereas a broad application of patents to nanomaterials, as well as the excessive cost of patenting and the absence of patent access facilities for very small businesses and small and medium-sized enterprises (SMEs), could stifle further innovation,
ker bo verjetno prišlo do združevanja nanotehnologije z biotehnologijo, biologijo, kognitivnimi vedami in informacijsko tehnologijo, kar odpira resna etična vprašanja ter vprašanja o varnosti in spoštovanju temeljnih pravic, ki jih je treba analizirati v novem mnenju evropske skupine za etiko v znanosti in novih tehnologijah,
whereas the likely convergence of nanotechnology with biotechnology, biology, cognitive sciences and information technology raises serious questions relating to ethics, safety, security and respect for fundamental rights that need to be analysed by a new opinion of the European Group on Ethics in Science and New Technologies,